Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.

Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH.

PLoS One. 2016 Oct 24;11(10):e0165382. doi: 10.1371/journal.pone.0165382.

2.

NCR1+ cells in dogs show phenotypic characteristics of natural killer cells.

Grøndahl-Rosado C, Bønsdorff TB, Brun-Hansen HC, Storset AK.

Vet Res Commun. 2015 Mar;39(1):19-30. doi: 10.1007/s11259-014-9624-z.

PMID:
25434421
3.

HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.

Dailey DD, Anfinsen KP, Pfaff LE, Ehrhart EJ, Charles JB, Bønsdorff TB, Thamm DH, Powers BE, Jonasdottir TJ, Duval DL.

BMC Vet Res. 2013 Jul 1;9:130. doi: 10.1186/1746-6148-9-130.

4.

Differential gene expression in brain tissues of aggressive and non-aggressive dogs.

Våge J, Bønsdorff TB, Arnet E, Tverdal A, Lingaas F.

BMC Vet Res. 2010 Jun 16;6:34. doi: 10.1186/1746-6148-6-34.

5.

Loss of heterozygosity at the FLCN locus in early renal cystic lesions in dogs with renal cystadenocarcinoma and nodular dermatofibrosis.

Bønsdorff TB, Jansen JH, Thomassen RF, Lingaas F.

Mamm Genome. 2009 May;20(5):315-20. doi: 10.1007/s00335-009-9183-8.

PMID:
19387735
6.

Second hits in the FLCN gene in a hereditary renal cancer syndrome in dogs.

Bønsdorff TB, Jansen JH, Lingaas F.

Mamm Genome. 2008 Feb;19(2):121-6. doi: 10.1007/s00335-007-9088-3.

PMID:
18219524
Items per page

Supplemental Content

Loading ...
Support Center